More on HUMA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.5 Score)

Upcoming Events

- Earnings (11/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Humacyte (NQ:HUMA)
Delayed: 0.43 -0.01 (2.27%)
Prev. Close $0.44  
Open$0.45 
52 Wk High$ 
52 Wk Low$ 
Day High$0.46 
Day Low$0.42 
P/E N/A  
EPS$ 
Volume5,969,772 

Friends, Peers and Foes (?): CRMD, KBLB SLRX (more...)

Oct 16, 2026 10:05 AM StoneX Reiterates Speculative Buy Rating on Humacyte (HUMA)
Oct 16, 2026 08:12 AM H.C. Wainwright Reiterates Buy Rating on Humacyte (HUMA)
Oct 15, 2026 08:06 AM Humacyte reports 44% rise in Symvess hospital orders in Q3
Oct 15, 2026 08:01 AM Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by Hospitals
Oct 12, 2026 08:00 AM Humacyte Phase 3 trial data to be presented at ASN Kidney Week
Oct 12, 2026 08:00 AM Humacyte Announces Phase 3 V012 Trial Results for ATEV in Women Requiring Hemodialysis Access Accepted for a Late-Breaking Session Presentation at ASN Kidney Week 2026
Oct 7, 2026 04:06 PM Form 4 Humacyte, Inc. For: Oct 06 Filed by: COWARD D SCOTT
Oct 7, 2026 04:05 PM Form 4 Humacyte, Inc. For: Oct 06 Filed by: Kuznik Paul Brian
Oct 6, 2026 04:25 PM Barclays Starts Humacyte (HUMA) at Equalweight
Sep 28, 2026 04:07 PM Form 3 Humacyte, Inc. For: Sep 22 Filed by: Kuznik Paul Brian
View All Articles

Entities mentioned with HUMA

View All Entities